2-(2-(Diphenylphosphino)ethyl)pyridine, 95.0%, 250mg

(2S,3R,4R,5S,6R)-2-(4-CHLORO-3-(4-ETHOXYBENZYL)PHENYL)-6-(HYDROXYMETHYL)TETRAHYDRO-2H-PYRAN-3,4,5-TRIOL COMPOUND WITH (S)-PROPANE-1,2-DIOL (1:1) HYDRATE, 95%, 250mg

2-Ethylhexyl 4-dimethylaminobenzoate, 95.0%, 50g

(4R,4'R)-2,2'-(1,3-DIPHENYLPROPANE-2,2-DIYL)BIS(4-METHYL-4,5-DIHYDROOXAZOLE), 95%, 5g

Pomalidomide-C2-amido-(C1-O-C5-O-C1)2-COOH, 100mg

2-((4-Methoxyphenyl)amino)-2-oxoacetic acid, 98%, 1g

(E)-2-Benzylidene-5-bromo-3-(cyclohexylamino)-2,3-dihydro-1H-inden-1-one, 98.0%, 25mg

2-(1H-Benzimidazol-2-yl)-4-bromophenol, 95.0%, 5g

N1-(Naphthalen-1-yl)ethane-1,2-diamine dihydrochloride, 95.0%, 5g

3-Fmoc-4-diaminobenzoic acid, 98.0%, 250mg

(2-[(2,4-Difluorophenyl)methoxy]phenyl)boranediol, 95%, 250mg

(E)-3-(2-Nitrovinyl)furan, 5g

3-Fluorobenzyl Bromide>97.0%(GC)25g